Intraperitoneal vancomycin‐induced immune thrombocytopenia

• Published in: Seminars in dialysis Vol. 35; no. 1; pp. 96 - 99
• Main Authors: Murt, Ahmet, Ozkan Tekin, Tuba, Guzel, Suleyman Sami, Olcar, Sercan, Salihoglu, Ayse, Ataman, Muveddet Rezzan
• Format: Journal Article
• Language: English
• Published: United States 01-01-2022
• Subjects: Anti-Bacterial Agents; Dexamethasone - adverse effects; Humans; Peritonitis - etiology; Purpura, Thrombocytopenic, Idiopathic - chemically induced; Purpura, Thrombocytopenic, Idiopathic - diagnosis; Purpura, Thrombocytopenic, Idiopathic - drug therapy; Renal Dialysis - adverse effects; Thrombocytopenia - chemically induced; Thrombocytopenia - complications; Thrombocytopenia - therapy; Vancomycin - adverse effects
• ISSN: 0894-0959; 1525-139X
• DOI: 10.1111/sdi.13024

Vancomycin is one of the drugs used in the peritonitis treatment regimen of peritoneal dialysis patients. Intraperitoneal route is generally preferred to provide rapid elimination of infective agents. Systemic toxicities of certain drugs after intraperitoneal administration are not very clear. The same also applies to vancomycin, although it has a considerable amount of systemic absorption after intraperitoneal administration. We herein report a case of severe thrombocytopenia, which was seen during the treatment of a peritonitis attack in a peritoneal dialysis patient. Culture studies revealed methicillin resistant staphylococci as the causative agent and the patient received intraperitoneal vancomycin per sensitivity analysis. Thrombocyte levels dropped abruptly to 3,900/μl after 10 days of vancomycin treatment. Clinical criteria pointed out to vancomycin‐related immune thrombocytopenia. Platelet levels did not recover with initial dexamethasone treatment and platelet transfusions. In the meantime, the clinical course was also complicated with intracranial bleeding. Intravenous immunoglobulin treatment was applied and dexamethasone was switched to high‐dose methylprednisolone. This latter treatment generated a response and platelet levels gradually increased to normal levels. The patient could be discharged without any sequelae. There have been two previous intraperitoneal vancomycin‐related immune thrombocytopenia cases in the literature. Previous cases were reviewed, and the present case was given in comparison with the previous cases.